Pultegroup (PHA) $PHA Sigma-Tau Pharmaceutical
Post# of 273257
Posted On: 09/05/2016 11:20:47 AM
Pultegroup (PHA) $PHA
Sigma-Tau Pharmaceuticals, Inc. Appoints Michael Minarich as Chief Executive Officer
BusinessWire - Thu Aug 04, 1:14PM CDT
Sigma-Tau Pharmaceuticals, Inc., today announced that its Board of Directors has appointed Michael Minarich as the Company's Chief Executive Officer (CEO), effective July 13, 2016. Mr. Minarich has served as interim Chief Executive Officer of the company since July 2015.
PHA: ()
Paul Edick Joins PDL BioPharma's Board of Directors
PR Newswire - Tue Sep 08, 6:02AM CDT
PDL BioPharma, Inc. ("PDL"
(NASDAQ: PDLI) today announced that Paul R. Edick has been appointed to the company's board of directors. Mr. Edick is currently managing partner of 3G Advisors, LLC, a consultancy to the pharmaceutical, healthcare and healthcare investor communities.
PHA: (), NLNK: 9.91 (-0.40), PDLI: 2.99 (+0.02)
Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
GlobeNewswire - Mon May 11, 3:15PM CDT
The Board of Directors of Phibro Animal Health Corporation (Nasdaq
AHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
PAHC: 25.86 (+0.27), PHA: (), NVS: 79.38 (+1.11)
Cleveland BioLabs Announces Appointment of Biotechnology Industry Veteran, Langdon Miller, MD, as President and Chief Medical Officer
Marketwired - Tue May 05, 6:30AM CDT
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Langdon L. Miller, M.D., as President and Chief Medical Officer, effective immediately.
PHA: (), PTCT: 7.91 (+0.12), CBLI: 1.86 (-0.13)
Sigma-Tau Pharmaceuticals, Inc. Appoints Michael Minarich as Chief Executive Officer
BusinessWire - Thu Aug 04, 1:14PM CDT
Sigma-Tau Pharmaceuticals, Inc., today announced that its Board of Directors has appointed Michael Minarich as the Company's Chief Executive Officer (CEO), effective July 13, 2016. Mr. Minarich has served as interim Chief Executive Officer of the company since July 2015.
PHA: ()
Paul Edick Joins PDL BioPharma's Board of Directors
PR Newswire - Tue Sep 08, 6:02AM CDT
PDL BioPharma, Inc. ("PDL"
(NASDAQ: PDLI) today announced that Paul R. Edick has been appointed to the company's board of directors. Mr. Edick is currently managing partner of 3G Advisors, LLC, a consultancy to the pharmaceutical, healthcare and healthcare investor communities. PHA: (), NLNK: 9.91 (-0.40), PDLI: 2.99 (+0.02)
Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
GlobeNewswire - Mon May 11, 3:15PM CDT
The Board of Directors of Phibro Animal Health Corporation (Nasdaq
AHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee. PAHC: 25.86 (+0.27), PHA: (), NVS: 79.38 (+1.11)
Cleveland BioLabs Announces Appointment of Biotechnology Industry Veteran, Langdon Miller, MD, as President and Chief Medical Officer
Marketwired - Tue May 05, 6:30AM CDT
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Langdon L. Miller, M.D., as President and Chief Medical Officer, effective immediately.
PHA: (), PTCT: 7.91 (+0.12), CBLI: 1.86 (-0.13)
(0)
(0)Scroll down for more posts ▼